Conference themes Accelerate the progression of ethical and effective antigen specific immunotherapies through the clinic, optimize the discovery of novel targets and explore novel therapeutic approaches harnessing combination therapies.Building on the success of the 2019 meeting, the 3rd Antigen Specific Immune Tolerance Summit (ASIT) returns to Boston on February 25-27, 2020. The meeting will bring together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation .
Professional congress organizer (PCO) Hanson Wade
Notes Speakers:
Kurt Griffin , Associate Professor, University of South Dakota Sanford School of Medicine, Andreas Lutterotti , Head of Experimental Therapies Research , University Hospital Zurich, Stephen Miller,Co-Founder of Cour Pharmaceuticals; & more
